Back to company

Biologik ApS: Financial statements 2022

CVR: 36070498

Biologik ApS (CVR 36070498) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 258,073 and a net result of DKK -89,361 compared with DKK 214,892 the year before. That is a decrease of 56.5% compared with the year before. Equity amounted to DKK 267,866. The solvency ratio was 61.2%. The company had 1 employee in the financial year.

Gross Profit
258,073 kr.
Profit/Loss
-89,361 kr.
Equity
267,866 kr.
Total Assets
437,363 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-258 t.-89 t.268 t.1
2021-593 t.215 t.414 t.1
2020-378 t.62 t.199 t.1
2019-832 t.183 t.237 t.1
2018-714 t.174 t.107 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Biologik ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About Biologik ApS

Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity amounted to DKK 408,578.